Founded by inventor Ross O. Youngs, Biosortia Microbiomics is a Columbus, Ohio company known for turning microbial-community chemistry into drug-discovery opportunities. Youngs brings nearly four decades of invention and more than 75 worldwide patents to a team led by pharmaceutical natural-products scientists, while the company’s Industrial-Scale Microbiome Mining platform gives researchers access to compounds that conventional small samples can miss. Its current lead focus is gut-restricted discovery for obesity and metabolic health.
NuBiyotaFounded in 2013, Guelph-based NuBiyota develops microbiome therapeutics designed to restore gut balance, using multi-strain microbial compositions delivered as drug products. The company’s Microbial Ecosystem Therapeutics platform grew from University of Guelph research led by co-founder Dr. Emma Allen-Vercoe and supports four clinical-stage candidates. NuBiyota conducts research in Guelph and operates a GMP manufacturing hub in Pearl River, New York, with a strategic collaboration with Takeda for gastrointestinal indications.PEARL RIVER, NY
Allied MicrobiotaAllied Microbiota grew out of a Columbia University microbiology lab and was founded in 2017 by environmental microbiologist Ray Sambrotto. The Stony Brook company develops FastBac microbial treatments for organizations facing difficult environmental cleanup challenges, with its research focused on turning naturally occurring microbes into scalable bioremediation tools.STONY BROOK, NY
ASAKE Biotechnology, LLCFounded in 2020 by three investigators from Ohio University’s Edison Biotechnology Institute, privately held ASAKE Biotechnology is an Athens company built around translating university research into new health therapeutics. Its scientists use natural resources to pursue treatments for serious diseases, while the company works with academic and Southeast Ohio partners to move promising discoveries toward practical medicines.ATHENS, OH
Digestive Care, IncFounded in 1990 by scientist Dr. Tibor Sipos, Bethlehem-based Digestive Care, Inc. develops and manufactures pharmaceutical treatments for gastrointestinal disorders, including the PERTZYE pancreatic enzyme replacement therapy. The company’s work grew from Sipos’s patented microencapsulation technology for protecting digestive enzymes during gastric transit, and PERTZYE is manufactured in the USA by DCI.325412BETHLEHEM, PA